Researchers Submit Patent Application, "Interrogatory Cell-Based Assays For Identifying Drug-Induced Toxicity Markers", for Approval (USPTO 20240161863).

A patent application has been submitted for a method of identifying drug-induced toxicity markers. The pharmaceutical industry faces challenges with clinical safety and adverse drug reactions, leading to high attrition rates and costs. The patent application describes a platform technology that integrates various biological tools to study drug-induced toxicity and identify biomarkers. This technology aims to improve predictability and efficiency in drug development and potentially reduce drug-induced toxicity. The method involves using cell-based assays to establish a model for drug-induced toxicity, obtaining data sets, generating a consensus causal relationship network, and identifying unique causal relationships associated with drug-induced toxicity. The patent application provides more details and claims related to the method. [Extracted from the article]